-
Je něco špatně v tomto záznamu ?
Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome
K. Sloupenska, J. Dolezilkova, B. Koubkova, B. Hutyrova, M. Racansky, P. Horak, M. Golovchenko, M. Raska, N. Rudenko, M. Krupka
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
grant IGA_LF_2021_015
Palacky University Olomouc
grant NV19-05-00191
Ministry of Health of the Czech Republic
NLK
Directory of Open Access Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2013-01-01
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
- Publikační typ
- časopisecké články MeSH
The hypothesized importance of coinfections in the pathogenesis of post-treatment Lyme disease syndrome (PTLDS) leads to the use of combined, ongoing antimicrobial treatment in many cases despite the absence of symptoms typical of the presence of infection with specific pathogens. Serum samples from 103 patients with suspected post-treatment Lyme disease syndrome were tested for the presence of antibodies to the major tick-borne pathogens Anaplasma phagocytophilum, Bartonella henselae/Bartonella quinatana, and Babesia microti. Although the presence of anti-Anaplasma antibodies was detected in 12.6% of the samples and anti-Bartonella antibodies in 9.7% of the samples, the presence of antibodies against both pathogens in the same samples or anti-Babesia antibodies in the selected group of patients could not be confirmed. However, we were able to detect autoantibodies, mostly antinuclear, in 11.6% of the patients studied. Our results are in good agreement with previously published studies showing the presence of a wide spectrum of autoantibodies in some patients with complicated forms of Lyme disease and post-treatment Lyme disease syndrome, but they do not reveal a significant influence of co-infections on the development of PTLDS in the studied group of patients.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22001469
- 003
- CZ-PrNML
- 005
- 20240717131353.0
- 007
- ta
- 008
- 220107s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/microorganisms9112217 $2 doi
- 035 __
- $a (PubMed)34835343
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Sloupenska, Kristyna $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 779 00 Olomouc, Czech Republic
- 245 10
- $a Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome / $c K. Sloupenska, J. Dolezilkova, B. Koubkova, B. Hutyrova, M. Racansky, P. Horak, M. Golovchenko, M. Raska, N. Rudenko, M. Krupka
- 520 9_
- $a The hypothesized importance of coinfections in the pathogenesis of post-treatment Lyme disease syndrome (PTLDS) leads to the use of combined, ongoing antimicrobial treatment in many cases despite the absence of symptoms typical of the presence of infection with specific pathogens. Serum samples from 103 patients with suspected post-treatment Lyme disease syndrome were tested for the presence of antibodies to the major tick-borne pathogens Anaplasma phagocytophilum, Bartonella henselae/Bartonella quinatana, and Babesia microti. Although the presence of anti-Anaplasma antibodies was detected in 12.6% of the samples and anti-Bartonella antibodies in 9.7% of the samples, the presence of antibodies against both pathogens in the same samples or anti-Babesia antibodies in the selected group of patients could not be confirmed. However, we were able to detect autoantibodies, mostly antinuclear, in 11.6% of the patients studied. Our results are in good agreement with previously published studies showing the presence of a wide spectrum of autoantibodies in some patients with complicated forms of Lyme disease and post-treatment Lyme disease syndrome, but they do not reveal a significant influence of co-infections on the development of PTLDS in the studied group of patients.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dolezilkova, Jana $u Laboratory of Medical Parasitology and Zoology, Public Health Institute Ostrava, Partyzanske Namesti 7, 702 00 Ostrava, Czech Republic
- 700 1_
- $a Koubková, Barbora $u Department of Allergology and Clinical Immunology, University Hospital Olomouc, I.P. Pavlova 185/6, 779 00 Olomouc, Czech Republic $7 xx0320139
- 700 1_
- $a Hutyrova, Beata $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 779 00 Olomouc, Czech Republic $u Department of Allergology and Clinical Immunology, University Hospital Olomouc, I.P. Pavlova 185/6, 779 00 Olomouc, Czech Republic
- 700 1_
- $a Racansky, Mojmir $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 779 00 Olomouc, Czech Republic $u Department of Allergology and Clinical Immunology, University Hospital Olomouc, I.P. Pavlova 185/6, 779 00 Olomouc, Czech Republic
- 700 1_
- $a Horak, Pavel $u Third Department of Internal Medicine-Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, I.P. Pavlova 185/6, 779 00 Olomouc, Czech Republic
- 700 1_
- $a Golovchenko, Maryna $u Institute of Parasitology, Biology Centre, Czech Academy of Sciences, Branisovska 1160/31, 370 05 Ceske Budejovice, Czech Republic
- 700 1_
- $a Raska, Milan $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 779 00 Olomouc, Czech Republic
- 700 1_
- $a Rudenko, Natalie $u Institute of Parasitology, Biology Centre, Czech Academy of Sciences, Branisovska 1160/31, 370 05 Ceske Budejovice, Czech Republic
- 700 1_
- $a Krupka, Michal $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 779 00 Olomouc, Czech Republic
- 773 0_
- $w MED00198767 $t Microorganisms $x 2076-2607 $g Roč. 9, č. 11 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34835343 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220107 $b ABA008
- 991 __
- $a 20240717131349 $b ABA008
- 999 __
- $a ind $b bmc $g 1745491 $s 1152616
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 9 $c 11 $e 20211025 $i 2076-2607 $m Microorganisms $n Microorganisms $x MED00198767
- GRA __
- $a grant IGA_LF_2021_015 $p Palacky University Olomouc
- GRA __
- $a grant NV19-05-00191 $p Ministry of Health of the Czech Republic
- LZP __
- $a Pubmed-20220107